Sign in

CIK 0001720580

  • Non-accelerated filer
  • Smaller reporting company

Adicet Bio, Inc.

Sign in to watch
Ticker
ACET
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 26
Incorporated
DE
Entity type
Operating
EIN
813305277
Phone
+1 617-482-2333
Business address
131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
Former names
resTORbio, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 50 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-05-10 Aftab Blake Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +60,000 60,000
2022-04-04 Galimi Francesco SVP & Chief Medical Officer Exercise or conversion +6,036 $13.27 $80K 65,953
2022-04-04 Galimi Francesco SVP & Chief Medical Officer Sale −6,036 $21.00 $127K 59,917
2022-04-04 Galimi Francesco SVP & Chief Medical Officer Exercise or conversion +168 $5.97 $1K 60,085
2022-04-04 Galimi Francesco SVP & Chief Medical Officer Sale −168 $21.00 $4K 59,917
2022-04-04 Galimi Francesco SVP & Chief Medical Officer Exercise or conversion +1,775 $16.82 $30K 61,692
2022-04-04 Galimi Francesco SVP & Chief Medical Officer Sale −1,775 $21.00 $37K 59,917
2022-04-04 Galimi Francesco SVP & Chief Medical Officer Exercise or conversion · Employee Stock Option (Right to Buy) −6,036 73,964
2022-04-04 Galimi Francesco SVP & Chief Medical Officer Exercise or conversion · Employee Stock Option (Right to Buy) −168 113,652
2022-04-04 Galimi Francesco SVP & Chief Medical Officer Exercise or conversion · Employee Stock Option (Right to Buy) −1,775 26,625
2022-04-01 Galimi Francesco SVP & Chief Medical Officer Exercise or conversion +7,621 $5.97 $45K 67,538
2022-04-01 Galimi Francesco SVP & Chief Medical Officer Sale −7,621 $21.00 $160K 59,917
2022-04-01 Galimi Francesco SVP & Chief Medical Officer Exercise or conversion · Employee Stock Option (Right to Buy) −7,621 113,820
2022-03-09 Jakobovits Aya Director Sale −2,000 $14.00 $28K 356,343
2022-03-09 Jakobovits Aya Director Sale −2,000 $14.00 $28K 356,345
2022-02-16 Jakobovits Aya Director Sale −2,000 $14.83 $30K 358,343
2022-02-16 Jakobovits Aya Director Sale −2,000 $14.83 $30K 358,345
2022-02-14 Healey Don Chief Technology Officer Grant or award +16,000 58,467
2022-02-14 Healey Don Chief Technology Officer Shares withheld for taxes −5,533 $14.27 $79K 52,934
2022-02-14 Aftab Blake Chief Scientific Officer Grant or award +16,000 58,436

Page 18 of 24 · 478 trades